In vitro vs in vivo- full Flashcards
(56 cards)
Headings (pneumonic)
TILOFC2HIHGC
Headings (list)
Introduction
Table 1 – pros and cons
Imaging
Lifespan
Obtaining tissues
Flow and environment
Cell lines
2D vs 3D cells
Human iPSCs
In vitro vs integrative systems vs computational models
High throughput screens and drug discovery
GWAS
Conclusions
Introduction subheadings (list)
In vitro vs ex vivo
Cell lines vs primary cells
In vivo
(Intro) In vitro vs ex vivo
● In vitro translates as ‘in a test tube’, while ex vivo means studying a tissue outside of the organism with minimal disturbance to the tissue itself.
● In vitro models are typically more reductionist than in vivo models.
● In vitro tests are designed to generate rapid, initial data that will give general insight into disease mechanisms and the biological effect of test compounds and materials.
(Intro) Cell lines vs primary cells
● Cell lines are immortalised but phenotypically abnormal.
● They have the capacity to proliferate indefinitely through natural or introduced mutations.
● The main advantages are that they are readily available, cheap, and easy to handle.
● In contrast, primary cells are short-lived and hard to obtain, but more representative of the tissue from which they are obtained in the patient.
● One of the major advantages of cell culture is the ability to manipulate the physicochemical and the physiological environment in which the cells propagate.
● However, modulating these factors may occur in a non-physiological way, in the absence of appropriate context (e.g. cytokine environment or cellular environment).
(Intro) In vivo
● In vivo models are commonly performed in rodents.
● However, there is scope for physiological studies to use human volunteers.
● Alternatively, in many studies looking to progress findings from rodent models to humans, either pigs or non-human primates.
● The fundamental issues of in vivo studies are the ethical concerns raised regarding excessive use of animals, and the low-throughput nature of the studies that must be conducted.
Table 1- pros and cons subheadings
Pros (in vivo, in vitro, ex vivo)
Cons (in vivo, in vitro, ex vivo)
Statistical power of models
(Table 1) Pros- in vivo
- Complete and truly physiologically relevant models
- Interconnectivity of organs: phenomenon observed at the scale of entire organism
- Long term studies
- Numerous well-established mouse models for cancer
(Table 1) Pros- in vitro
- All human cells
- Control of cellular, biochemical, and biophysical content
- High throughput
- High resolution imaging
(Table 1) Pros- ex vivo
- True and complex local cellular and extracellular microenvironment
- Conserved local microarchitecture
- Easier for imaging than in vivo
(Table 1) Cons- in vivo
- Ethical issues
- Expensive
- Low throughput
- Nonhuman microenvironment
- Imaging is hard and expensive
- Limited control of microenvironment
(Table 1) Cons- in vitro
- Isolated system: no systemic analysis
- Not long term
- Limited physiological relevance, incomplete microenvironment
- Use of genetically homogeneous cell lines
(Table 1) Cons- ex vivo
- Isolated from rest of organism
- Limited in time
- Requires access to fresh living tissue
(Table 1) Statistical power of models
● It is much quicker and cheaper to develop an in vitro model than to develop an animal model. Furthermore, when the in vitro model is developed, experiments can be performed in much higher throughput.
● This means that in vitro experiments are significantly more likely to get sufficient numbers of biological and technical repeats to achieve statistical significance.
● The number of animals used in studies must be weighed up against the concerns regarding the over-use of animals.
● Therefore, many studies will only use biological repeats of 5-10, which can result in a failure to achieve statistical significance.
Imaging subheadings (list)
Higher resolution imaging– observing calcium sparks in CPVT
Jiang 2004
(Imaging) Higher resolution imaging– observing calcium sparks in CPVT
● Another advantage of in vitro studies is the ability to perform much higher resolution imaging, including live cell microscopy.
● Jiang 2004 used cell lines loaded with fluo3-AM and confocal line-span microscopy to observe calcium sparks in CPVT.
● CPTV is an inherited condition that causes cardiac arrhythmias.
● The disease is caused by a variety of different mutations in the ryanodine receptor apparatus, including calsequestrin and triadin.
● However, the most common mutation that causes CPVT1 is to the RyR2 channel itself.
(Imaging) Jiang 2004
● Jiang et al in 2004 showed that these RyR2 mutations were gain of function.
● The authors transfected either wild-type or CPVT-mutant RyR2s into HEK293 cell lines and loaded them with fluo3-AM.
● Under confocal line-scan microscopy, the occurrence of Ca2+ sparks was significantly higher in HEK cells transfected with CPVT-mutant RyR2 channels.
● However, the use of the embryonic kidney line raises questions as to the validity of these results in myocytes.
● Nonetheless, these findings have been supported by more recent studies in isolated ventricular myocytes from both humans and mouse models.
Lifespan subheadings (list)
Limited lifespan and chronic diseases
Shan 2010 and ryanodine receptor in chronic heart failure
(Lifespan) Limited lifespan and chronic diseases
● However, the flip side of the high throughput advantage is that in vitro models typically have limited lifespan, making it difficult to model chronic diseases.
● Shan 2010 used a mice model to build on the genetic aberrations from the cell line in CPVT, and to identify modulation by intracellular kinases in prolonged conditions such as chronic heart failure
(Lifespan) Shan 2010 and ryanodine receptor in chronic heart failure
● The ryanodine receptor is not just affected by genetic aberrations in CPVT, instead there can be modulation by intracellular kinases.
● This can occur particularly in prolonged conditions such as chronic heart failure.
● Shan et al in 2010 used a mice model of a constitutively hyperphosphorylated RyR2.
● The authors developed a RyR2 S2808D knockin mice model.
● The authors found that mimicking chronic PKA phosphorylation with isoproterenol caused cardiomyopathy with significantly reduced ejection fraction in the knockin mice.
● When these channels were isolated and recorded in the presence of 150nM calcium, the single channel patch clamp recordings in lipid bilayers showed that these channels had a greater open probability.
● After myocardial infarction, these mice were more pre-disposed to ventricular tachycardia and death following the LAD ligation model of MI.
● Together, these findings demonstrate that the chronic hyperphosphorylation of RyR2 in heart failure predisposes to the development of arrhythmia due to increased open probability of the RyR2 channel.
● It would have been interesting for the authors to study calcium transients with calcium dyes in myocytes isolated from the canine models, to determine the frequency of arrhythmogenic events.
Obtaining tissue subheadings (list)
Difficulties in obtaining tissues from humans
Heather 2011 (new)
(Obtaining tissue) Difficulties in obtaining tissues from humans
● Whilst tissue from biopsies and post-mortem is optimal for the study of human physiology and diseases, this tissue is often difficult to obtain.
● For example, heart tissue and atrial appendages can often be obtained by patients undergoing routine surgery to excise tissue to treat atrial fibrillation.
● Whilst this is a good model of the disease, it is also important to note it is difficult to gather tissue from control patients.
(Obtaining tissue) Heather 2011 (new)
● Heather et al in 2011 used cardiac biopsies from patients undergoing surgery for aortic stenosis in Western blots for fatty acid translocase (FAT) and GLUT4.
● Quantification of these Western blot bands showed a negative correlation between FAT and GLUT4 expression, with higher GLUT4 and lower FAT associated with the greatest hypertrophy in the 18 patients recruited for the study.
● However, there was an unavoidable lack of a control group, as biopsy tissue is less readily available from healthy trial participants.
● Obtaining post-mortem tissue is also difficult, given precedence is often given to organ transplants for patients.